Alternative strategies

Carmignac Portfolio Long-Short European Equities

Luxembourg SICAV sub-fundEuropean marketArticle 8
Share Class

LU0992627298

A high-conviction long/short approach to European equities
  • A bottom-up fundamental approach to maximise long and short alpha generation.
  • Active management of the net equity exposure (-20% to +50%) ensuring great responsiveness to market fluctuations.
  • Risk management at the core of our investment process to limit volatility and downside risk.
Key documents
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
3 years
Cumulative Performance since launch
+ 99.6 %
+ 98.8 %
+ 30.5 %
+ 37.8 %
+ 10.1 %
From 15/11/2013
To 04/09/2026
Calendar Year Performance 2025
+ 10.0 %
+ 16.7 %
+ 5.1 %
+ 0.3 %
+ 7.4 %
+ 13.6 %
- 5.7 %
+ 0.7 %
+ 18.0 %
+ 8.3 %
Net Asset Value
€199.6
Asset Under Management
817 M €
Net Equity Exposure31/08/2026
20.2%
SFDR - Fund Classification

Article

8
Data as of:  4 Sep 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

Carmignac Portfolio Long-Short European Equities fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  31 Aug 2026.

Market environment

  • August was characterized by continued stock-specific dispersion rather than a strong directional market move.
  • The Stoxx 600 finished the month higher, supported by a generally constructive earnings season, resilient economic data and continued optimism surrounding artificial intelligence-related investment.
  • While macroeconomic concerns remained present, investors focused primarily on corporate fundamentals, rewarding companies able to demonstrate earnings resilience and improved visibility despite an uncertain economic backdrop.
  • Investors increasingly rewarded companies exposed to structural investment themes, particularly electrification, power infrastructure and industrial automation, while businesses tied to discretionary consumer spending and segments of healthcare equipment and life sciences continued to face more challenging earnings revisions.

Performance commentary

  • In August, the fund delivered a positive performance, driven by the Long book.
  • On the Long side, Public Power Corporation was our largest contributor, after releasing a robust set of results.
  • The company continued to benefit from increasing investor confidence in the management's transformation strategy, as the company moves from a legacy regulated utility model towards a more balanced generation portfolio, with growing exposure to renewables and continued operational discipline.
  • Saipem was our second largest contributor, following a series of contract awards and positive industry data points that reinforced confidence in the durability of the offshore investment cycle.
  • Siltronic benefited from improving investor sentiment towards the semiconductor supply chain. While near-term wafer demand remains subdued, management commentary reinforced our view that the industry is progressing through the latter stages of a cyclical inventory correction.
  • On the short side, our medtech positions did particularly well. Fresenius Medical Care reported weaker than expected patient growth in the US dialysis business and lowered its outlook for US volume growth. Smith & Nephew also reported Q2 revenue below expectations and reduced its full year revenue growth guidance.

Outlook strategy

  • The net exposure of the strategy stayed in the 20s throughout the month.
  • We remain constructive on the Long side in industries such as specialty engineering, specialty chemicals, utilities, medical technology, aerospace and defense, and semiconductors.
  • We remain constructive on Europe in 2026, as the fiscal stimulus and low rates provide an attractive tailwind.
  • Germany has removed the fiscal drag which has weighted on Europe for more than a decade and the upcoming defense and infrastructure historic investment plan will have a profound impact on the overall region.
  • Our portfolio remains focused on stock specific and idiosyncratic drivers, rather than macro plays.
  • On the short side, we continue to find many new names in the Consumer and Industrials spaces with poor balance sheets and deteriorating fundamentals, bringing tightened margins and profit warnings.

Performance Overview

Data as of:  4 Sep 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.
From 1 January 2022, the Fund’s investment objective is an absolute performance objective.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 07/09/2026

Carmignac Portfolio Long-Short European Equities Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  31 Aug 2026.
Europe EUR31.4%
North America10.9%
Others1.5%
Equity Basket Derivatives-4.5%
Europe ex-EUR-7.0%
Index Derivatives-12.1%
View details

Key figures

Below are some key figures to help you understand the Fund's management and positioning.

Exposure Data

Data as of:  31 Aug 2026.
Net Equity Exposure20.2%
Beta+0.4
Sortino Ratio+1.0
Number of Holdings21

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
We strive to build a high-conviction portfolio of long and short positions, based on a thorough fundamental company analysis to identify the best opportunities in Europe.
[Management Team] [Author] Heininger Malte

Malte HEININGER

Delegated Fund Manager, White Creek Capital LLP
Source and Copyright: Citywire. Malte HEININGER is A rated by Citywire for his/her rolling three-year risk-adjusted performance across all funds the manager is managing to the 31 July 2026. Citywire Fund Manager Ratings and Citywire Rankings are proprietary to Citywire Financial Publishers Ltd (“Citywire”) and © Citywire 2025. All rights reserved. The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager. Past performance is not necessarily indicative of future performance.
View Fund's characteristics

Articles that may interest you

Events8 July 2026English

Carmignac Summer Insights Conference 2026

2 minute(s) read
Find out more
Strategies insights14 November 2024English

Carmignac Portfolio Long Short European Equities: Letter from the Fund Manager

2 minute(s) read
Find out more
Strategies insights22 August 2024English

Carmignac Portfolio Long-Short European Equities: Letter from the Fund Manager

2 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.